SAN FRANCISCO and SAN ANTONIO, Aug. 24, 2022 /PRNewswire/ -- LumaBridge (formerly known as Cancer Insight), a clinical research organization (CRO) dedicated to discovering, developing, and testing ...

Cytokines are small, secreted proteins that transmit messages between cells and members of this superfamily include chemokines, growth factors, interleukins, interferons, colony stimulating factors, ...

Studies published in Nature Cancer reveal how bacterial presence in head and neck cancers affects treatment response, ...

The gut microbiome has been shown to influence tumor growth and contribute to therapeutic resistance. Scientists have ...

Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why ...

Tevogen Bio Holdings Inc. has announced its new artificial intelligence initiative, Tevogen.AI™, aimed at enhancing its ExacTcell™ technology for improved target identification and preclinical ...

REDWOOD CITY, Calif. & SHENZHEN, China--(BUSINESS WIRE)--LTZ Therapeutics, an immunotherapy-focused biotech company, today announced the completion of the company’s Series A financing of over $20 ...

The "Cancer Immunotherapy Drug Discovery Outsourcing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Cancer Immunotherapy Drug ...

Silica nanomaterial cuts immunotherapy costs while boosting cancer treatment efficacy by nearly 70% in animal studies.

INCHEON, South Korea, Oct. 19, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has entered into a partnership agreement with BioEleven to develop and manufacture BN-101A, a third-generation ...

BEIJING--(BUSINESS WIRE)--Sartorius Stedim Biotech (SSB), a leading international supplier of the biopharmaceutical industry, through its China affiliate, and Beijing-based Immunochina Pharmaceuticals ...

NEW YORK and VIENNA, Austria, Feb. 13, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (HOOK) (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapies based on its proprietary ...